4,4,4-Trifluoro-1-(p-Tolyl)-1,3-Butanedione CAS 720-94-5 Celecoxib Puritas media >99.0% (GC)
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica 4,4,4-Trifluoro-1-(p-Tolyl)-1,3-Butanedione (CAS: 720-94-5) magna qualitas, media magni momenti. de Celecoxib (CAS: 169590-42-5).Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Celecoxib Intermedia,Please contact: alvin@ruifuchem.com
| Nomen chemicum | 4,4,4-Trifluoro-1-(p-Tolyl)-1,3-Butanedione |
| Synonyma | 4,4,4-Trifluoro-1-(4-Methylphenyl)-1,3-Butanedione;4,4,4-Trifluoro-1-(p-Tolyl)butane-1,3-Dione;4,4,4-Trifluoro-1-(4-Methylphenyl)butane-1,3-Dione;1-(4-Methylphenyl) -4,4,4-Trifluorobutane-1,3-Dione |
| immunditia | Celecoxib Related Compound 4;Celecoxib - Impuritas G |
| Stock Status | In Stock, Commercial Productio |
| CAS Number | 720-94-5 |
| Formulae hypotheticae | C11H9F3O2 |
| M. Pondus | 230.19 g/mol |
| Liquescens punctum | 45.0 ad 49.0℃ |
| Density | 1.252±0.06 g/cm3 |
| Sensitiva | Calor Sensitiva |
| Solubilitas | Solutum in Methanol |
| COA & MSDS | Praesto |
| Sample | Praesto |
| Origin | Shanghai, China |
| Brand | Ruifu Chemical |
| Items | Signa inspectionis | Proventus |
| Aspectus | Lux Yellow ad Yellow pulverem | Flavus pulveris |
| Liquescens punctum | 45.0~49.0℃ | Obsequitur |
| Aquae Caroli Fischer | <0.50% | 0.2% |
| Puritas / Analysis Methodus | >99.0% (GC) | 99.8% |
| Infrared Imaginis | Congruunt Structure | Obsequitur |
| 1H NMR Imaginum | Congruunt Structure | Obsequitur |
| conclusio | Productum probatum est et cum datis specificationibus obsequitur | |
| Applicationem | Medium Celecoxib (CAS: 169590-42-5) | |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Periculosam symbola Xi - Irritant
Periculum Codes 36/37/38 - Irritando ad oculos, systema respiratorium et cutem.
Salus Descriptio
S26 - In contactu cum oculis, statim cum aqua multa ablue et consilium medicinae quaeras.
S36/37/39 - Indumentum tutelae idoneum, caestus et oculi/facies tutelam gerunt.
Aleam Class INRITANT
4,4,4-Trifluoro-1-(p-Tolyl)-1,3-Butanedione (CAS: 720-94-5) media est Celecoxib (CAS: 169590-42-5).Celecoxib et Rofecoxib duo inhibitores nunc COX-2 sunt usi.Feliciter evoluta a GD Searle & Pfizer Co. (US,) anno 1999, nomen artis: Celebrex.Celecoxib est agens nonsteroidale, anti-inflammatorium cum effectibus analgesicis et anti-inflammatoriis significantibus, causans infimum tractus ulcerum gastrointestinalium superiorum incidentes et alia inpedimenta.Usus amet ut tractaret osteoarthritis et arthritis et rheumatoideis acutis et longis, cum anti-inflammatione analgesico munere, sublevandis signis et symptomatibus osteoarthritis et arthritis rheumatoideis.Celecoxib medicamentum nonsteroidale antiinflammatorium (NSAID) primum in US Celebrex inducitur ad curationem symptomatum in aegris cum arthritis rheumatoideis (RA) et osteoarthritis (OA).
